31results about How to "Precise recipe" patented technology

The invention discloses a food, health-care product or pharmaceutical composition for curing chronic hepatitis B. The food, health-care product or pharmaceutical composition is prepared from the following crude drugs in parts by weight: 10 to 20 parts of rhizoma polygoni cuspidati, 15 to 25 parts of penthorum chinense pursh herb, 10 to 20 parts of herba verbenae, 19 to 29 parts of phyllanthus urinaria herb, 10 to 20 parts of lightyellow sophora root and 10 to 20 parts of radix curcumae. The invention further discloses a preparation method and application of the pharmaceutical composition. The pharmaceutical composition can effectively cure the chronic hepatitis B and is good in application prospect.

The invention provides a traditional Chinese medicine composition with the function of promoting calculus expulsion, which is prepared from the raw materials in the following weight proportions: 10.5-19.5 parts of aconite, 7-13 parts of cinnamon, 14-26 parts of Cornus officinalis, 14-26 parts of Rehmannia glutinosa, 21-39 parts of Paeoniae Alba, 48.5-51.5 parts of Achyranthes bidentata, 21-39 parts of money grass, 21-39 parts of Haijinsha, 21-39 parts of stone reed, 48.5-51.5 parts of gallinaceous gold, talc 21-39 parts, 7-13 parts of saltpeter, 10.5-19.5 parts of licorice. The invention also provides the preparation method and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition provided by the invention has a precise formula, and has great advantages in promoting stone excretion, can effectively treat ureteral calculi, and prevent stones from forming stone streets in the ureter in patients with urinary calculi who receive extracorporeal shock wave lithotripsy, and the combination of the present invention The drug is safe, has no toxic and side effects, and is convenient to use, providing a new drug option for clinical practice.

The invention discloses a pharmaceutical composition for treating hypertension, which is a preparation prepared from raw materials in the following weight ratio: 4-20 parts of Evodia rutaecarpa, 10-30 parts of Codonopsis pilosula, 10-30 parts of Chinese jujube, gastrodia elata 10-30 parts, Uncaria 10-30 parts, Cassia 20-60 parts, Scutellaria baicalensis 10-30 parts, Prunella vulgaris 10-30 parts, Angelica 10-20 parts, Salvia miltiorrhiza 15-40 parts, Inula 10-30 parts 30 parts, 15-30 parts of ochre, 10-20 parts of Tongcao, 10-20 parts of turmeric, 3-15 parts of licorice. The pharmaceutical composition of the invention can effectively treat hypertension, and has good clinical application prospect.

The invention provides a pharmaceutical composition for treating chronic obstructive pulmonary disease in the stable stage, which is a preparation prepared from the raw materials in the following weight proportions: 10-30 parts of Radix Astragali Radix, 5-15 parts of Schisandra Fructus, honey 10-20 parts of Inula inula, 10-20 parts of Codonopsis pilosula, 10-20 parts of fried Atractylodes macrocephala, 5-15 parts of dried ginger, 10-20 parts of French pinellia, 10-20 parts of tangerine peel, 10-30 parts of rehmannia glutinosa, dogwood 10 to 20 parts, 5 to 15 parts of cinnamon, 10 to 20 parts of angelica, 5 to 15 parts of bellflower, 10 to 20 parts of poria cocos, 1 to 4 parts of asarum, and 3 to 6 parts of roasted licorice. The pharmaceutical composition provided by the invention has a precise formula, can significantly alleviate the clinical symptoms of patients with stable chronic obstructive pulmonary disease, and effectively treat stable chronic obstructive pulmonary disease, and the composition of the present invention has good safety, no toxic and side effects, and is convenient to use , providing a new drug option for the clinical treatment of stable chronic obstructive pulmonary disease.

The invention discloses a food, health product and medicinal composition for treating the non-alcoholic fatty liver disease, which is a preparation prepared from the following raw material medicines by weight: 20 to 40 parts of raw fructus crataegi, 20 to 40 parts of scorched fructus crataegi, 10 to 30 parts of medicated leaven, 10 to 20 parts of rhizoma atractylodis macrocephalae, 10 to 30 parts of folium nelumbinis, 5 to 15 parts of rhizoma alismatis, 10 to 20 parts of rhizoma curcumae longae, 5 to 15 parts of cassiae semen, and 3 to 9 parts of rhizoma coptidis. The invention further discloses a preparation method and application of the composition. The medicinal composition disclosed by the invention can effectively treat the non-alcoholic fatty liver disease, and has a wide application prospect.

The invention provides food, a health product or a medicinal composition for treating yang jaundice. The food, health product or medicinal composition is a preparation prepared from the following medicinal raw materials in parts by weight: 19-42 parts of penthorum chinense, 2-7 parts of coptis chinensis, 23-40 parts of capillary artemisia, 9-18 parts of radix curcumae, 10-19 parts of radix paeoniae rubra, 20-37 parts of poria cocos, 25-36 parts of malt, 22-43 parts of haws, 7-21 parts of pericarpium citri reticulatae and 17-36 parts of licorice roots. Experiment results prove that the food, health product or medicinal composition has an exact formula, can be used for effectively treating yang jaundice, provides a choice for clinically treating yang jaundice, and has an excellent application prospect.

The invention provides a pharmaceutical composition for treating bronchiectasis in the stable phase, which is a preparation prepared from raw materials with the following weight proportions: Codonopsis 20-40 parts, Poria cocos 10-20 parts, French half 10-20 parts of summer, 10-20 parts of tangerine peel, 10-20 parts of bran-fried Atractylodes macrocephala, 10-20 parts of amomum, 5-15 parts of woody fragrance, 5-15 parts of raw licorice, 20-40 parts of yam, 20 parts of coix seed ~40 parts, 5~15 parts of wine skullcap, 20~40 parts of sunburned astragalus, 5~15 parts of Schisandra chinensis, 10~30 parts of lily, 10~20 parts of Moutan cortex, 10~20 parts of rehmannia glutinosa. The pharmaceutical composition provided by the invention has a precise formula, can alleviate the clinical symptoms and signs of patients with stable bronchiectasis, and slow down the progress of the disease. Moreover, the composition of the invention has good safety, no toxic and side effects, and is easy to use. It is suitable for clinical treatment of stable bronchiectasis. A new drug option is offered.